129 related articles for article (PubMed ID: 27487889)
21. Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease.
Li D; Liu Y; Zeng X; Xiong Z; Yao Y; Liang D; Qu H; Xiang H; Yang Z; Nie L; Wu PY; Wang R
J Alzheimers Dis; 2020; 78(1):439-452. PubMed ID: 32986675
[TBL] [Abstract][Full Text] [Related]
22. Olfactory cortex degeneration in Alzheimer's disease and mild cognitive impairment.
Vasavada MM; Wang J; Eslinger PJ; Gill DJ; Sun X; Karunanayaka P; Yang QX
J Alzheimers Dis; 2015; 45(3):947-58. PubMed ID: 25633674
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer's Disease Classification Based on Individual Hierarchical Networks Constructed With 3-D Texture Features.
Liu J; Wang J; Hu B; Wu FX; Pan Y
IEEE Trans Nanobioscience; 2017 Sep; 16(6):428-437. PubMed ID: 28541903
[TBL] [Abstract][Full Text] [Related]
24. Brain iron deposition in type 2 diabetes mellitus with and without mild cognitive impairment-an in vivo susceptibility mapping study.
Yang Q; Zhou L; Liu C; Liu D; Zhang Y; Li C; Shang Y; Wei X; Li C; Wang J
Brain Imaging Behav; 2018 Oct; 12(5):1479-1487. PubMed ID: 29297155
[TBL] [Abstract][Full Text] [Related]
25. Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.
Eustache P; Nemmi F; Saint-Aubert L; Pariente J; Péran P
J Alzheimers Dis; 2016; 50(4):1035-50. PubMed ID: 26836151
[TBL] [Abstract][Full Text] [Related]
26. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
27. Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
Jahng GH; Oh J; Lee DW; Kim HG; Rhee HY; Shin W; Paik JW; Lee KM; Park S; Choe BY; Ryu CW
J Alzheimers Dis; 2016 Mar; 52(1):145-59. PubMed ID: 27060946
[TBL] [Abstract][Full Text] [Related]
28. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
[TBL] [Abstract][Full Text] [Related]
29. Altered spontaneous activity in Alzheimer's disease and mild cognitive impairment revealed by Regional Homogeneity.
Zhang Z; Liu Y; Jiang T; Zhou B; An N; Dai H; Wang P; Niu Y; Wang L; Zhang X
Neuroimage; 2012 Jan; 59(2):1429-40. PubMed ID: 21907292
[TBL] [Abstract][Full Text] [Related]
30. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
31. Local susceptibility causes diffusion alterations in patients with Alzheimer's disease and mild cognitive impairment.
Jahng GH; Xu S
Brain Imaging Behav; 2012 Sep; 6(3):426-36. PubMed ID: 22415193
[TBL] [Abstract][Full Text] [Related]
32. Quantitative Susceptibility Mapping of Brain Iron Relating to Cognitive Impairment in Hypertension.
Qin Z; Wu W; Liu D; Zheng C; Kang J; Zhou H; Meng X; Haacke EM; Wang L
J Magn Reson Imaging; 2022 Aug; 56(2):508-515. PubMed ID: 34989062
[TBL] [Abstract][Full Text] [Related]
33. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance.
Bosch B; Arenaza-Urquijo EM; Rami L; Sala-Llonch R; Junqué C; Solé-Padullés C; Peña-Gómez C; Bargalló N; Molinuevo JL; Bartrés-Faz D
Neurobiol Aging; 2012 Jan; 33(1):61-74. PubMed ID: 20371138
[TBL] [Abstract][Full Text] [Related]
34. A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227.
Kaneta T; Okamura N; Minoshima S; Furukawa K; Tashiro M; Furumoto S; Iwata R; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H
Ann Nucl Med; 2011 Dec; 25(10):732-9. PubMed ID: 21792587
[TBL] [Abstract][Full Text] [Related]
35. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
[TBL] [Abstract][Full Text] [Related]
36. Multiple diffusion indices reveals white matter degeneration in Alzheimer's disease and mild cognitive impairment: a tract-based spatial statistics study.
Shu N; Wang Z; Qi Z; Li K; He Y
J Alzheimers Dis; 2011; 26 Suppl 3():275-85. PubMed ID: 21971467
[TBL] [Abstract][Full Text] [Related]
37. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
38. Pitfalls of voxel-based amyloid PET analyses for diagnosis of Alzheimer's disease: artifacts due to non-specific uptake in the white matter and the skull.
Arai A; Kaneta T; Okamura N; Tashiro M; Iwata R; Takanami K; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H
Tohoku J Exp Med; 2014 Nov; 234(3):175-81. PubMed ID: 25311079
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous voxel-based magnetic susceptibility and morphometry analysis using magnetization-prepared spoiled turbo multiple gradient echo.
Kan H; Uchida Y; Arai N; Ueki Y; Aoki T; Kasai H; Kunitomo H; Hirose Y; Matsukawa N; Shibamoto Y
NMR Biomed; 2020 May; 33(5):e4272. PubMed ID: 32043682
[TBL] [Abstract][Full Text] [Related]
40. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
Suppa P; Hampel H; Spies L; Fiebach JB; Dubois B; Buchert R;
J Alzheimers Dis; 2015; 46(1):199-209. PubMed ID: 25720402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
